Selectins: initiators of leucocyte adhesion and signalling at the vascular wall. (20th May 2015)

• Record Type: Journal Article
• Authors: McEver, Rodger P.
• Is Part Of: Cardiovascular research. Volume 107:Number 3(2015)
• Page Start: 331
• Page End: 339
• Publication Date: 2015-05-20
• Subjects: Neutrophil -- Selectin -- Integrin -- Cell adhesion -- Inflammation; Cardiovascular system -- Diseases -- Periodicals; Cardiovascular system -- Periodicals; 616.1
• DOI: 10.1093/cvr/cvv154
• Languages: English
• ISSNs: 0008-6363

Abstract

Abstract: The selectins are transmembrane, Ca 2+ -dependent lectins that mediate leucocyte rolling on vascular surfaces, the first adhesive step during inflammation and immune surveillance. Leucocytes express L-selectin, activated platelets express P-selectin, and activated endothelial cells express E- and P-selectin. Rolling involves force-regulated, rapidly reversible interactions of selectins with a limited number of glycosylated cell surface ligands. Rolling permits leucocytes to interact with immobilized chemokines that convert β2 integrins to high-affinity conformations, which mediate arrest, post-arrest adhesion strengthening, and transendothelial migration. However, rolling leucocytes also transduce signals through selectin ligands, the focus of this review. These signals include serial activation of kinases and recruitment of adaptors that convert integrins to intermediate-affinity conformations, which decrease rolling velocities. In vitro, selectin signalling enables myeloid cells to respond to suboptimal levels of chemokines and other agonists. This cooperative signalling triggers effector responses such as degranulation, superoxide production, chemokine synthesis, and release of procoagulant/proinflammatory microparticles. In vivo, selectin-mediated adhesion and signalling likely contributes to atherosclerosis, arterial and deep vein thrombosis, ischaemia–reperfusion injury, and other cardiovascular diseases.